English
SeQuent Scientific Q3 Results
- BSE: 512529
- NSE: SEQUENT
- ISIN: INE807F01027
- Sector: Biotechnology & Drugs
BSE
198.55
-7.05 (-3.43%)
-7.05 (-3.43%)Volume42.14 K
Updated: Tue 20 Jan, 2026 | 15:25:19
NSE
199.43-6.25 (-3.04%)
-6.25 (-3.04%)Volume8.94 L
Updated: Tue 20 Jan, 2026 | 15:40:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - SeQuent Scientific Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 374.14 | 353.50 | 5.84% | 319.16 | 17.23% |
| Depreciation/ Amortization | 16.98 | 17.10 | -0.70% | 15.46 | 9.87% |
| Operating Income | 16.67 | 15.15 | 10.03% | 10.20 | 63.48% |
| Net Income | 3.44 | 2.61 | 31.80% | 8.27 | -58.39% |
| Other Operating Expenses Total | 79.10 | 69.75 | 13.41% | 67.98 | 16.36% |
| Net Income Before Taxes | 8.10 | 7.90 | 2.53% | 1.49 | 443.26% |
| Total Revenue | 390.81 | 368.65 | 6.01% | 329.36 | 18.66% |
| Selling/ General/ Admin Expenses Total | 75.22 | 67.04 | 12.20% | 57.86 | 30.01% |
| Diluted Normalized EPS | 0.14 | 0.23 | -40.14% | 0.26 | -46.06% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.